COMMUNIQUÉS West-GlobeNewswire

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré

17/10/2024 - 18:00

OSE Immunotherapeutics présente une nouvelle technologie bispécifique de « Cis-Démasquage » pour la conception de médicaments à base de cytokines avec un indice thérapeutique amélioré Nantes, France, le 17 octobre 2024 [...]

EssilorLuxottica: Q3/9M 2024 Revenue - Revenue keeping a solid 4% growth

17/10/2024 - 18:00

Q3/9M 2024 Revenue Revenue keeping a solid 4% growth Group’s revenue up 4.0% at constant exchange rates 1 in Q3, +4.9% year to date Revenue positive in both segments in all the regions in Q3 North America up low-single [...]

EssilorLuxottica: Chiffre d’affaires T3/9M 2024 - Solide croissance du chiffre d'affaires à +4 %

17/10/2024 - 18:00

Chiffre d’affaires T3/9M 2024 Solide croissance du chiffre d'affaires à +4 % Hausse de 4,0 % du chiffre d’affaires à taux de change constants 1 au troisième trimestre, +4,9 % depuis le début de l'année Croissance du [...]

Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

17/10/2024 - 17:45

KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope 1 +8.6% including companion animals +11.9% farm animals +3.2% Growth at constant exchange rates 2 +14.0% Overall change + [...]

VIRBAC: Croissance soutenue du chiffre d’affaires à fin septembre de +12,6% et +8,6% à taux de change et périmètre constants. Maintien des objectifs pour 2024.

17/10/2024 - 17:45

CHIFFRES CLÉS Chiffre d’affaires à fin septembre 2024 1 042,1 M€ Croissance à taux de change et périmètre constants 1 +8,6% dont animaux de compagnie +11,9% animaux d’élevage +3,2% Croissance à taux de change constants [...]

Emergex Announces Company Name Change to “Gylden Pharma Limited” Reflecting Company’s Commitment to Advanced Core Technologies and Expanded Product Pipeline

17/10/2024 - 17:00

ABINGDON, United Kingdom, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited, a clinical-stage biotechnology company that is addressing major global infectious diseases through the development of [...]

Dr. Wenming Chen to Receive Asian Myeloma Network Distinguished Service Award at the 8th AMN Summit in Seoul

17/10/2024 - 16:41

International Myeloma Foundation (IMF) to hold AMN Awards Ceremony at the 8th AMN Summit in Seoul, South Korea on Saturday, October 19 SEOUL, South Korea, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The International Myeloma [...]

Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney Injury at the American Society for Nephrology (ASN Kidney Week 2024)

17/10/2024 - 16:24

BALTIMORE, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a leader in the field of non-degrading molecular glues, is pleased to announce the upcoming presentation of preclinical in vivo data from its [...]

New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women

17/10/2024 - 16:00

NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using the EnPlace ® device, a [...]

WellRithms Selected for BenefitsPRO’s 2024 Luminaries Awards

17/10/2024 - 16:00

PORTLAND, Ore., Oct. 17, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, has been named to BenefitsPRO Luminaries Class of 2024 in the Rising Star category, one of only two recipients [...]

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

17/10/2024 - 15:41

-- LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy— -- Granted Orphan Drug Exclusivity in [...]

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

17/10/2024 - 15:32

Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient [...]

TOMI Environmental Solutions, Inc. Announces Record Q3 2024 iHP Corporate Service Revenue

17/10/2024 - 15:25

FREDERICK, Md., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced that its iHP Corporate [...]

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17/10/2024 - 15:15

AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest [...]

Nordic Naturals Completes 40th Annual California Coastal Cleanup with National Retail Support

17/10/2024 - 15:00

WATSONVILLE, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals , a worldwide leader in providing premium omega-3 fish oils and other essential nutrient supplements, successfully wrapped up its participation in [...]

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

17/10/2024 - 15:00

SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which [...]

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

17/10/2024 - 15:00

Access the CEO Connect segment here ISELIN, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the [...]

Solera Health Study Suggests Virtual Healthcare Networks Can Reduce the Cost of Care by up to 3.1%

17/10/2024 - 15:00

Potential Savings Equate to Over $50 Billion in U.S. Annual Private Insurer Expenditures PHOENIX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Solera Health , a unique technology platform for connecting people seamlessly and [...]

Adial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Expanded Genotype Combinations Identified Using the Company’s Genetic Diagnostic for Addiction Treatment

17/10/2024 - 15:00

Expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence GLEN ALLEN, Va., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc [...]